THRIVE VENTURES, LTD.

Thesis

The firm is known for its founder-centric approach, patient capital deployment, and long-term conviction in transformative technologies. Thrive Capital employs a flexible, multi-stage investment strategy, actively participating in rounds from pre-seed through pre-IPO and even growth and late-stage investments. The firm's geographic scope is global, with a strong presence in the United States, particularly New York City and San Francisco. Thrive Capital's strategy involves making fewer, more substantial bets with a high conviction, aiming for concentrated portfolios rather than spreading capital thinly across many startups. In recent years, there has been an increasing focus on Artificial Intelligence (AI) and machine learning investments, including foundation models and applied AI solutions across various verticals. Other strategic areas of focus include internet, software, media, healthcare, and fintech. As of early 2025, Thrive Capital manages approximately $15.57 billion in assets, with other reports indicating Assets Under Management (AUM) of $15.6 billion and over $50 billion as of December 31, 2025. The firm has raised substantial funds, with Thrive IX closing at over $5 billion in August 2024, comprising a $4 billion late-stage fund and a $1 billion early-stage fund. Thrive X, closed in February 2026, exceeded $10 billion. While specific check sizes per deal are not explicitly detailed, Thrive Capital's strategy of making 'fewer but more substantial bets' and its significant fund sizes suggest that their investments are typically substantial, particularly in later-stage rounds. For instance, Thrive led OpenAI's $6.6 billion fundraising round in October 2024, contributing approximately $1.3 billion. They also invested $1 billion in Stripe's Series I financing round.

Related lists

• Pre-seed AI investors
• Pre-seed Fintech investors
• Pre-seed Healthcare investors